Similar articles

• Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X.

  Reith W, Satola S, Sanchez CH, Amaldi I, Lisowska-Grospierre B, Griscelli C, Hadam MR, Mach B. Reith W, et al. Cell. 1988 Jun 17;53(6):897-906. doi: 10.1016/s0092-8674(88)90389-3. Cell. 1988. PMID: 3133120
• The down-regulation of HLA-DM gene expression in rheumatoid arthritis is not related to their promoter polymorphism.

  Louis-Plence P, Kerlan-Candon S, Morel J, Combe B, Clot J, Pinet V, Eliaou JF. Louis-Plence P, et al. J Immunol. 2000 Nov 1;165(9):4861-9. doi: 10.4049/jimmunol.165.9.4861. J Immunol. 2000. PMID: 11046010
• NF-X, a transcription factor implicated in MHC class II gene regulation.

  Kouskoff V, Mantovani RM, Candéias SM, Dorn A, Staub A, Lisowska-Grospierre B, Griscelli C, Benoist CO, Mathis DJ. Kouskoff V, et al. J Immunol. 1991 May 1;146(9):3197-204. J Immunol. 1991. PMID: 2016543
• Class II MHC genes: a model gene regulatory system with great biologic consequences.

  Ting JP, Zhu XS. Ting JP, et al. Microbes Infect. 1999 Sep;1(11):855-61. Microbes Infect. 1999. PMID: 10614002 Review. No abstract available.
• Combined immunodeficiency with defective expression in MHC class II genes.

  Griscelli C, Lisowska-Grospierre B, Mach B. Griscelli C, et al. Immunodefic Rev. 1989;1(2):135-53. Immunodefic Rev. 1989. PMID: 2517209 Review.